NASDAQ:CGEN
Compugen Ltd. Stock News
$2.11
-0.0300 (-1.40%)
At Close: May 17, 2024
Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential
07:00am, Thursday, 16'th May 2024
HOLON, Israel, May 16, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced th
Compugen Appoints David Silberman as Chief Financial Officer
07:00am, Wednesday, 15'th May 2024
HOLON, Israel , May 15, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced th
Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024
07:00am, Monday, 06'th May 2024
HOLON, ISRAEL , May 6, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced t
HOLON, Israel , April 25, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE:CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announce
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
07:00am, Wednesday, 10'th Apr 2024
HOLON, Israel , April 10, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announce
Compugen to Participate in Two Upcoming Investor Conferences
07:00am, Wednesday, 03'rd Apr 2024
HOLON, Israel , April 3, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announce
Are You Looking for a Top Momentum Pick? Why Compugen (CGEN) is a Great Choice
01:01pm, Tuesday, 12'th Mar 2024
Does Compugen (CGEN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy
07:00am, Monday, 11'th Mar 2024
HOLON, Israel , March 11, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced
Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024
07:00am, Wednesday, 06'th Mar 2024
HOLON, Israel , March 6, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced
Compugen Ltd. (CGEN) Q4 2023 Earnings Call Transcript
02:41pm, Tuesday, 05'th Mar 2024
Compugen Ltd. (NASDAQ:CGEN ) Q4 2023 Earnings Conference Call March 5, 2024 8:30 AM ET Company Participants Yvonne Naughton - Head of Investor Relations and Corporate Communications Anat Cohen-Dayag -
Compugen Reports Fourth Quarter and Full Year 2023 Results
07:00am, Tuesday, 05'th Mar 2024
Partnership with Gilead on preclinical immuno-oncology program further validates Compugen's computational discovery, research, and development capabilities Catalyst rich 2024 expected with multiple da
Is a Surprise Coming for Compugen (CGEN) This Earnings Season?
10:01am, Thursday, 29'th Feb 2024
Compugen (CGEN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Compugen to Present at the Leerink Partners Global Biopharma Conference 2024
07:00am, Monday, 26'th Feb 2024
HOLON, Israel , Feb. 26, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announc
Compugen (CGEN) is a Great Momentum Stock: Should You Buy?
01:01pm, Wednesday, 21'st Feb 2024
Does Compugen (CGEN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024
07:00am, Tuesday, 20'th Feb 2024
HOLON, Israel , Feb. 20. 2024 /PRNewswire/ -- Compugen Ltd.
